Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Immuno-Biological Lab, The Current Fiscal Year Ordinary Profit Revised Upward to an Unexpected 44% Increase, Highest in Twenty Two Terms
Immuno-Biological Lab, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 5.2 times, Exceeds Full-Year Plan
Immuno-Biological Laboratories Co., Ltd., First Half Ordinary Profit Increases by 2.1 times